Clinical Trials Insight: 700031667

Trial Profile

Clinical Trials Insight: 700031667

Planning
Phase of Trial: Phase III

Latest Information Update: 18 Mar 2008

At a glance

  • Drugs Cyclophosphamide; Fludarabine; Oblimersen
  • Indications Chronic lymphocytic leukaemia
  • Focus Registrational; Therapeutic Use
  • Sponsors Genta (CEASED)
  • Most Recent Events

    • 18 Mar 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top